Scientific Reports (Jun 2022)

Functional and morphologic dysfunctions in the airways of rats submitted to an experimental model of obesity-exacerbated asthma

  • Sarah Rebeca Dantas Ferreira,
  • Rayane Fernandes Pessoa,
  • Indyra Alencar Duarte Figueiredo,
  • João Pedro Moura Lima,
  • Thayna Maria Costa Fernandes de Moura,
  • Cleyton Oliveira Bezerra,
  • Alissa Maria de Oliveira Martins,
  • Leila Moreira de Carvalho,
  • Marta Suely Madruga,
  • Hassler Clementino Cavalcante,
  • Jailane de Souza Aquino,
  • José Luiz de Brito Alves,
  • Adriano Francisco Alves,
  • Luiz Henrique César Vasconcelos,
  • Fabiana de Andrade Cavalcante

DOI
https://doi.org/10.1038/s41598-022-13551-0
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 18

Abstract

Read online

Abstract The obesity-exacerbated asthma phenotype is characterized by more severe asthma symptoms and glucocorticoid resistance. The aim of this study was to standardize an obesity-exacerbated asthma model by a high glycemic level index (HGLI) diet and ovalbumin (OVA) sensitization and challenges in Wistar rats. Animals were divided into groups: control (Ctrl), obese (Ob), asthmatic (Asth), obese asthmatic (Ob + Asth) and obese asthmatic treated with dexamethasone (Ob + Asth + Dexa), and in vivo and in vitro functional and morphological parameters were measured. After HGLI consumption, there was an increase in body weight, fasting blood glucose, abdominal circumferences, body mass index and adiposity index. Respiratory function showed a reduction in pulmonary tidal volume and ventilation. In isolated tracheas, carbachol showed an increase in contractile efficacy in the Ob, Ob + Asth and Ob + Asth + Dexa, but mostly on Ob + Asth. Histological analysis of lungs showed peribronchovascular inflammation and smooth muscle hypertrophy and extracellular remodeling on Ob + Asth and Ob + Asth + Dexa. An obesity-exacerbated asthma model was successfully established. Therefore, this model allows further molecular investigations and the search for new therapies for the treatment and relief of symptoms of patients with obesity-induced resistant asthma.